Tg Therapeutics (TGTX) Research & Development (2016 - 2025)
Historic Research & Development for Tg Therapeutics (TGTX) over the last 10 years, with Q3 2025 value amounting to $40.9 million.
- Tg Therapeutics' Research & Development rose 10298.94% to $40.9 million in Q3 2025 from the same period last year, while for Sep 2025 it was $142.9 million, marking a year-over-year increase of 6263.13%. This contributed to the annual value of $94.3 million for FY2024, which is 2375.45% up from last year.
- As of Q3 2025, Tg Therapeutics' Research & Development stood at $40.9 million, which was up 10298.94% from $31.8 million recorded in Q2 2025.
- Tg Therapeutics' 5-year Research & Development high stood at $63.1 million for Q1 2021, and its period low was $14.8 million during Q3 2023.
- Its 5-year average for Research & Development is $33.5 million, with a median of $29.6 million in 2022.
- Per our database at Business Quant, Tg Therapeutics' Research & Development plummeted by 6696.64% in 2023 and then soared by 10618.78% in 2024.
- Quarter analysis of 5 years shows Tg Therapeutics' Research & Development stood at $62.6 million in 2021, then crashed by 52.69% to $29.6 million in 2022, then tumbled by 41.12% to $17.4 million in 2023, then surged by 36.82% to $23.9 million in 2024, then skyrocketed by 71.22% to $40.9 million in 2025.
- Its Research & Development stands at $40.9 million for Q3 2025, versus $31.8 million for Q2 2025 and $46.4 million for Q1 2025.